Robert Huizinga Insider Profile

4 Followers
Robert Huizinga, Executive Vice-President - Research & Development at Aurinia Pharmaceuticals, holds 69.38K shares in Aurinia Pharmaceuticals (Ticker: AUPH), holds 332.00K shares in Kane Biotech (Ticker: TSE:KNE). Most recently, Robert Huizinga ― shares of Aurinia Pharmaceuticals on ― for an estimated value of ―.
tipranks
Robert Huizinga

Robert Huizinga
Aurinia Pharmaceuticals (AUPH)
Executive Vice-President - Research & Development

Ranked #50,907 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-1.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$601K
94.56%
5.44%
A breakdown of Robert Huizinga's holdings

Insider Roles

Aurinia Pharmaceuticals
(AUPH)
Executive Vice-President - Research & Development
Kane Biotech
(KNE)
Chairman
Roles that Robert Huizinga holds in companies

Most Profitable Insider Trade

Stock:
Kane Biotech
(KNE)
Rating:Informative Buy
Date:Oct 02, 2024 - Today
Return:0.00%
The most profitable trade made by Robert Huizinga

Robert Huizinga's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aurinia Pharmaceuticals
Executive Vice-President - Research & Development
$577.23K
Kane Biotech
Oct 02, 2024
Chairman
Informative Buy
30.25K
C$33.20K
List of latest transactions for each holding click on a transaction to see Robert Huizinga's performance on stock

Robert Huizinga insider profile FAQ

What is the percentage of profitable transactions made by Robert Huizinga?
The percentage of profitable transactions made by Robert Huizinga is 0%.
    What is the average return per transaction made by Robert Huizinga?
    The average return per transaction made by Robert Huizinga is -1.80%.
      What stocks does Robert Huizinga hold?
      Robert Huizinga holds: AUPH, TSE:KNE stocks.
        What was Robert Huizinga’s latest transaction?
        Robert Huizinga latest transaction was an Uninformative Buy of ―.
          What was Robert Huizinga's most profitable transaction?
          Robert Huizinga’s most profitable transaction was an Informative Buy of TSE:KNE stock on October 2, 2024. The return on the trade was 0.00%.
            What is Robert Huizinga's role in Aurinia Pharmaceuticals?
            Robert Huizinga's role in Aurinia Pharmaceuticals is Executive Vice-President - Research & Development.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.